Chronic Obstructive Pulmonary Disease (COPD) — which includes emphysema and chronic bronchitis — is the long-term lung disease most closely associated with smoking. The question: does vaping cause COPD too?
What the Studies Show
The honest answer: we don't have enough long-term data to know for sure. COPD takes decades to develop. Vaping has only been widespread since roughly 2010-2014 in the US. That's simply not enough time for population-level COPD studies to mature.
What we do have:
- Cross-sectional studies show that vapers report more respiratory symptoms (cough, wheezing, phlegm) than non-vapers, but fewer than smokers (Wang et al., 2022; FDA Tobacco Product Scientific Advisory Committee, 2024)
- Switching studies show that smokers who switch to vaping see improvements in respiratory symptoms compared to those who keep smoking (Huang et al., 2021; Hajek et al., 2019)
- Animal studies show lung inflammation and tissue changes from high-dose vape exposure, but these use concentrations far above typical human use (Li et al., 2023; NIH/NIDA grants)
Important: Many studies that claim "vaping causes COPD" suffer from a critical flaw: they fail to adequately control for former smoking status. Most adult vapers are former smokers. If former smokers who vape have higher COPD rates than never-smokers, that tells you more about the harm from past smoking than the harm from vaping. Look for studies that separate "ex-smokers who vape" from "never-smokers who vape."
The Bottom Line on COPD
We will not have definitive answers about vaping and COPD until vapers have been followed for 20-30 years. Based on what we know now — no tar, no combustion, dramatically reduced carcinogen exposure — it is biologically plausible that vaping carries substantially lower COPD risk than smoking. But "plausible" is not "proven." For current smokers, the calculus is clear: switching reduces harm. For never-smokers, the calculus is equally clear: don't start.
